Prognostic Significance of CD27 and CD56 on Newly Diagnosed MM Patients Treated with Bortezomib / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 827-831, 2021.
Article
Dans Chinois
| WPRIM
| ID: wpr-880154
ABSTRACT
OBJECTIVE@#To investigate the significance of CD27 and CD56 in the prognosis of multiple myeloma (MM) patients, and to establish a simple and convenient prognostic risk score.@*METHODS@#One hundred and eleven newly diagnosed MM patients treated by bortezomib in Shengjing hospital from January 1, 2013 to January 1, 2019 were selected, and the relationship between clinical characteristics and survival time of patients was analyzed.@*RESULTS@#The overall survival (OS) of patients in CD27@*CONCLUSION@#Among patients with MM treated by bortezomib, CD27
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pronostic
/
Études rétrospectives
/
Transplantation de cellules souches hématopoïétiques
/
Antigènes CD56
/
Bortézomib
/
Myélome multiple
Type d'étude:
Étude observationnelle
/
Étude pronostique
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Journal of Experimental Hematology
Année:
2021
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS